Novelion Therapeutics Provides Update on Agreement between Aegerion Pharmaceuticals and U.S. Department of Justice
November 21, 2017 08:30 ET
|
Novelion Therapeutics, Inc.
VANCOUVER, British Columbia, Nov. 21, 2017 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ:NVLN), a biopharmaceutical company dedicated to developing new standards of care for individuals...
Novelion Therapeutics Reports Third Quarter 2017 Financial Results and Announces Leadership Change
November 09, 2017 08:28 ET
|
Novelion Therapeutics, Inc.
Company Reiterates FY 2017 Guidance for Total Net Revenues of $135-$145 millionCompany Announces Leadership Change and Search for Chief Executive Officer VANCOUVER, British Columbia, Nov. 09, 2017 ...
Novelion Therapeutics Expands Leadership Team with Appointment of Jeffrey Hackman as Chief Operating Officer
October 31, 2017 08:30 ET
|
Novelion Therapeutics, Inc.
VANCOUVER, British Columbia, Oct. 31, 2017 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ:NVLN), a biopharmaceutical company dedicated to developing new standards of care for individuals...
Novelion Therapeutics Strengthens Leadership Team with Appointment of Murray Stewart, M.D., as Executive Vice President, Head of R&D
October 12, 2017 09:15 ET
|
Novelion Therapeutics, Inc.
VANCOUVER, British Columbia, Oct. 12, 2017 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ:NVLN), a biopharmaceutical company dedicated to developing new standards of care for individuals...
Novelion Therapeutics Observes Familial Hypercholesterolemia Awareness Day
September 24, 2017 08:00 ET
|
Novelion Therapeutics, Inc.
VANCOUVER, British Columbia, and CAMBRIDGE, Mass., Sept. 24, 2017 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ:NVLN), a biopharmaceutical company dedicated to developing new standards of...
Metreleptin and Lipodystrophy Data Presented at the International Meeting of Pediatric Endocrinology
September 15, 2017 08:30 ET
|
Novelion Therapeutics, Inc.
VANCOUVER, British Columbia and CAMBRIDGE, Mass., Sept. 15, 2017 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ:NVLN), a biopharmaceutical company dedicated to developing new standards of...
Novelion Therapeutics Appoints Suzanne Bruhn, Ph.D. to Board of Directors
September 11, 2017 08:30 ET
|
Novelion Therapeutics, Inc.
VANCOUVER, British Columbia, Sept. 11, 2017 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ:NVLN), a biopharmaceutical company dedicated to developing new standards of care for individuals...
Novelion Therapeutics Reports Second Quarter 2017 Financial Results
August 08, 2017 07:00 ET
|
Novelion Therapeutics, Inc.
MYALEPT® Total Net Revenues Increase 28% Over Prior Quarter, Excluding One-Time AdjustmentsGlobal Expansion Plans for Metreleptin Opportunity UnderwayCompany Updates Guidance for FY 2017 Total Net...
Novelion Therapeutics Appoints Mark DiPaolo to Board of Directors
August 02, 2017 08:30 ET
|
Novelion Therapeutics, Inc.
VANCOUVER, British Columbia, Aug. 02, 2017 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ:NVLN), a biopharmaceutical company dedicated to developing new standards of care for individuals...
Novelion Therapeutics to Announce Second Quarter 2017 Financial Results on August 8, 2017
July 28, 2017 08:30 ET
|
Novelion Therapeutics, Inc.
VANCOUVER, British Columbia, July 28, 2017 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ:NVLN), a biopharmaceutical company dedicated to developing new standards of care for individuals...